These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30030687)

  • 1. NRAL mediates cisplatin resistance in hepatocellular carcinoma via miR-340-5p/Nrf2 axis.
    Wu LL; Cai WP; Lei X; Shi KQ; Lin XY; Shi L
    J Cell Commun Signal; 2019 Mar; 13(1):99-112. PubMed ID: 30030687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-340 reverses cisplatin resistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway.
    Shi L; Chen ZG; Wu LL; Zheng JJ; Yang JR; Chen XF; Chen ZQ; Liu CL; Chi SY; Zheng JY; Huang HX; Lin XY; Zheng F
    Asian Pac J Cancer Prev; 2014; 15(23):10439-44. PubMed ID: 25556489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA Unigene56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells.
    Lv J; Fan HX; Zhao XP; Lv P; Fan JY; Zhang Y; Liu M; Tang H
    Cancer Lett; 2016 Nov; 382(2):166-175. PubMed ID: 27597739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance.
    Meng W; Tai Y; Zhao H; Fu B; Zhang T; Liu W; Li H; Yang Y; Zhang Q; Feng Y; Chen G
    Med Sci Monit; 2017 Mar; 23():1295-1304. PubMed ID: 28291769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141.
    Wu L; Pan C; Wei X; Shi Y; Zheng J; Lin X; Shi L
    Cell Commun Signal; 2018 Aug; 16(1):47. PubMed ID: 30119680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. circRNA circARNT2 Suppressed the Sensitivity of Hepatocellular Carcinoma Cells to Cisplatin by Targeting the miR-155-5p/PDK1 Axis.
    Li Y; Zhang Y; Zhang S; Huang D; Li B; Liang G; Wu Y; Jiang Q; Li L; Lin C; Wei Z; Meng L
    Mol Ther Nucleic Acids; 2021 Mar; 23():244-254. PubMed ID: 33425483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells.
    Chen Y; Zhao H; Li H; Feng X; Tang H; Qiu C; Zhang J; Fu B
    Mol Ther Nucleic Acids; 2020 Mar; 19():168-178. PubMed ID: 31838274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Growth-Arrest-Specific Transcript 5 Improved Cisplatin Sensitivity in Hepatocellular Carcinoma Through Sponging miR-222.
    Zhao P; Cui X; Zhao L; Liu L; Wang D
    DNA Cell Biol; 2020 Apr; 39(4):724-732. PubMed ID: 32213078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA-DANCR Interferes With miR-125b-5p/HK2 Axis to Desensitize Colon Cancer Cells to Cisplatin vis Activating Anaerobic Glycolysis.
    Shi H; Li K; Feng J; Liu G; Feng Y; Zhang X
    Front Oncol; 2020; 10():1034. PubMed ID: 32766131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA LINC00173 enhances cisplatin resistance in hepatocellular carcinoma via the microRNA-641/RAB14 axis.
    Zhao G; Zhang A; Sun S; Ding Y
    Oncol Lett; 2021 May; 21(5):371. PubMed ID: 33777195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-coding RNA FENDRR Acts as a miR-423-5p Sponge to Suppress the Treg-Mediated Immune Escape of Hepatocellular Carcinoma Cells.
    Yu Z; Zhao H; Feng X; Li H; Qiu C; Yi X; Tang H; Zhang J
    Mol Ther Nucleic Acids; 2019 Sep; 17():516-529. PubMed ID: 31351327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
    Wang YG; Wang T; Shi M; Zhai B
    J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA LINC00461/miR-149-5p/LRIG2 axis regulates hepatocellular carcinoma progression.
    Ji D; Wang Y; Li H; Sun B; Luo X
    Biochem Biophys Res Commun; 2019 Apr; 512(2):176-181. PubMed ID: 30879766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-21-5p Suppressed the Sensitivity of Hepatocellular Carcinoma Cells to Cisplatin by Targeting FASLG.
    Chen S; Yang C; Sun C; Sun Y; Yang Z; Cheng S; Zhuge B
    DNA Cell Biol; 2019 Aug; 38(8):865-873. PubMed ID: 31225740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Long Non-coding RNA, MSTRG.51053.2 Regulates Cisplatin Resistance by Sponging the miR-432-5p in Non-small Cell Lung Cancer Cells.
    Zhang J; Xu C; Gao Y; Wang Y; Ding Z; Zhang Y; Shen W; Zheng Y; Wan Y
    Front Oncol; 2020; 10():215. PubMed ID: 32158694
    [No Abstract]   [Full Text] [Related]  

  • 18. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
    Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
    Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
    Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W
    J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.